Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation - PubMed (original) (raw)
Chondroitin sulfate proteoglycan immunoreactivity increases following spinal cord injury and transplantation
M L Lemons et al. Exp Neurol. 1999 Nov.
Abstract
Extrinsic factors appear to contribute to the lack of regeneration in the injured adult spinal cord. It is likely that these extrinsic factors include a group of putative growth inhibitory molecules known as chondroitin sulfate proteoglycans (CSPGs). The aims of this study were to determine: (1) the consequences of spinal cord contusion injury on CSPG expression, (2) if CSPGs can be degraded in vivo by exogenous enzyme application, and (3) the effects of intraspinal transplantation on the expression of CSPGs. Chondroitin 6-sulfate proteoglycan immunoreactivity (CSPG-IR) dramatically increased following spinal cord contusion injury both at and adjacent to the injury site compared to normal controls (no surgical procedure) and laminectomy-only controls by 4 days postinjury. The dramatic increase in CSPG-IR persisted around the lesion and in the dorsal one-half to two-thirds of the spinal cord for at least 40 days postinjury. Glial fibrillary acidic protein (GFAP)-IR patterns were similarly intensified and spatially restricted as CSPG-IR patterns. These results suggest that: (1) CSPGs may contribute to the lack of regeneration following spinal cord injury and (2) astrocytes may contribute to the production of CSPGs. In addition, our results show that CSPGs could be cleaved in vivo with exogenous chondroitinase ABC application. This demonstration of cleavage may the basis for a model to directly assess CSPGs' role in growth inhibition in vivo (studies in progress) and hold potential as a therapeutic approach to enhance growth. Interestingly, the robust, injury-induced CSPG-IR patterns were not altered by intraspinal grafts of fetal spinal cord. The CSPG expression profile in the host spinal cord was similar to time-matched contusion-only animals. This was also true of GFAP-IR patterns. Furthermore, the fetal spinal cord tissue, which was generally CSPG negative at the time of transplantation, developed robust CSPG expression by 30 days posttransplantation. This increase in CSPG expression in the graft was paired with a moderate increase in GFAP-IR. CSPG-IR patterns suggest that these molecules may contribute to the limited regeneration seen following intraspinal transplantation. In addition, it suggests that the growth permissiveness of the graft may change overtime as CSPG expression develops within the graft. These correlations in the injured and transplanted spinal cord support CSPGs' putative growth inhibitory effect in the adult spinal cord.
Similar articles
- Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury.
Ikegami T, Nakamura M, Yamane J, Katoh H, Okada S, Iwanami A, Watanabe K, Ishii K, Kato F, Fujita H, Takahashi T, Okano HJ, Toyama Y, Okano H. Ikegami T, et al. Eur J Neurosci. 2005 Dec;22(12):3036-46. doi: 10.1111/j.1460-9568.2005.04492.x. Eur J Neurosci. 2005. PMID: 16367770 - Single, high-dose intraspinal injection of chondroitinase reduces glycosaminoglycans in injured spinal cord and promotes corticospinal axonal regrowth after hemisection but not contusion.
Iseda T, Okuda T, Kane-Goldsmith N, Mathew M, Ahmed S, Chang YW, Young W, Grumet M. Iseda T, et al. J Neurotrauma. 2008 Apr;25(4):334-49. doi: 10.1089/neu.2007.0289. J Neurotrauma. 2008. PMID: 18373483 - ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans.
Chan CC, Wong AK, Liu J, Steeves JD, Tetzlaff W. Chan CC, et al. Glia. 2007 Mar;55(4):369-84. doi: 10.1002/glia.20466. Glia. 2007. PMID: 17136770 - [Axonal growth inhibition by chondroitin sulfate proteoglycans in the central nervous system].
Díaz-Martínez NE, Velasco I. Díaz-Martínez NE, et al. Rev Invest Clin. 2009 Mar-Apr;61(2):140-9. Rev Invest Clin. 2009. PMID: 19637728 Review. Spanish. - Scar-mediated inhibition and CSPG receptors in the CNS.
Sharma K, Selzer ME, Li S. Sharma K, et al. Exp Neurol. 2012 Oct;237(2):370-8. doi: 10.1016/j.expneurol.2012.07.009. Epub 2012 Jul 24. Exp Neurol. 2012. PMID: 22836147 Free PMC article. Review.
Cited by
- Building-Block Size Mediates Microporous Annealed Particle Hydrogel Tube Microenvironment Following Spinal Cord Injury.
Ross BC, Kent RN 3rd, Saunders MN, Schwartz SR, Smiley BM, Hocevar SE, Chen SC, Xiao C, Williams LA, Anderson AJ, Cummings BJ, Baker BM, Shea LD. Ross BC, et al. Adv Healthc Mater. 2024 Oct;13(25):e2302498. doi: 10.1002/adhm.202302498. Epub 2023 Oct 5. Adv Healthc Mater. 2024. PMID: 37768019 - Recovery of Forearm and Fine Digit Function After Chronic Spinal Cord Injury by Simultaneous Blockade of Inhibitory Matrix Chondroitin Sulfate Proteoglycan Production and the Receptor PTPσ.
Milton AJ, Kwok JCF, McClellan J, Randall SG, Lathia JD, Warren PM, Silver DJ, Silver J. Milton AJ, et al. J Neurotrauma. 2023 Dec;40(23-24):2500-2521. doi: 10.1089/neu.2023.0117. Epub 2023 Oct 11. J Neurotrauma. 2023. PMID: 37606910 Free PMC article. - Thermo-sensitive hydrogel combined with SHH expressed RMSCs for rat spinal cord regeneration.
Gu J, Gao B, Zafar H, Chu B, Feng X, Ni Y, Xu L, Bao R. Gu J, et al. Front Bioeng Biotechnol. 2022 Oct 21;10:1001396. doi: 10.3389/fbioe.2022.1001396. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36338109 Free PMC article. - The Role of Extracellular Matrix in Human Neurodegenerative Diseases.
Pintér P, Alpár A. Pintér P, et al. Int J Mol Sci. 2022 Sep 21;23(19):11085. doi: 10.3390/ijms231911085. Int J Mol Sci. 2022. PMID: 36232390 Free PMC article. Review. - A Concise Review of Extraction and Characterization of Chondroitin Sulphate from Fish and Fish Wastes for Pharmacological Application.
Urbi Z, Azmi NS, Ming LC, Hossain MS. Urbi Z, et al. Curr Issues Mol Biol. 2022 Aug 28;44(9):3905-3922. doi: 10.3390/cimb44090268. Curr Issues Mol Biol. 2022. PMID: 36135180 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous